Advik Capital is a non-banking financial company that provides industrial loans, bridge financing, and investment services to corporate and retail clients.
The company lacks a durable competitive advantage, as evidenced by negative net margins and an average ROCE of 2.4%, which is significantly below the cost of capital. There is no evidence of low-cost funding or unique underwriting capabilities that would provide a scale or cost edge over larger financial institutions.
Capital allocation has been poor, characterized by heavy reinvestment into lending activities that have resulted in substantial losses and asset quality concerns. The company frequently seeks fresh capital through rights issues and debt limit increases despite failing to generate positive returns on existing equity.
The company's collapse was precipitated by the realization of its massive credit risks, as the 92.40 crore in questionable loans—already flagged by auditors—proved entirely unrecoverable. Regulatory scrutiny intensified following the Enforcement Directorate investigations, leading to a complete freeze on operations and an inability to raise further capital through dilutive rights issues. As the negative cash conversion cycle persisted and interest coverage remained underwater, the business model effectively became a machine for incinerating shareholder equity to fund unapproved related-party transactions.
RichFakir rates Advik Capital Ltd's business quality as poor — 13/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Advik Capital Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Advik Capital Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Advik Capital Ltd's fair value is about ₹0 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →